{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:06:56Z","timestamp":1779530816913,"version":"3.53.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,5]]},"abstract":"<jats:p>Dantrolene, 1st synthesized in 1967, is widely used for treating malignant hyperthermia (MH), neuroleptic malignant syndrome, and spasticity. However, comprehensive analysis of its adverse effects and underlying mechanisms remains limited. This study aims to analyze dantrolene-associated adverse events (AEs) using pharmacovigilance databases, with particular focus on subgroup analysis comparing MH versus non-MH patients, and investigate their underlying molecular mechanisms. We analyzed AEs from 3 pharmacovigilance databases (U.S. Food and Drug Administration Adverse Event Reporting System [2004\u20132024], Japanese Adverse Drug Event Report [2004\u20132023], Canada Vigilance Adverse Reaction Online Database [1991\u20132019]) and conducted differential gene expression analysis using GEO datasets (GSE184769, GSE227229). Signal detection employed disproportionality analysis using reporting odds ratio (ROR), proportional reporting ratio, Bayesian confidence propagation neural network, and Empirical Bayesian Geometric Mean indices. Analysis revealed significant respiratory and musculoskeletal AEs. Respiratory failure was consistently reported across databases (ROR: 29.33\u201346.29), while musculoskeletal complications included rhabdomyolysis (ROR: 14.05) and compartment syndrome (ROR: 80.52). MH patients showed increased risks of muscular weakness (ROR: 19.00), respiratory failure (ROR: 5.48), and pulmonary edema (ROR: 22.18). Molecular analysis identified IL6 and ALB as key mediators of respiratory effects, while Adgrl1 and Adgrl2 emerged as crucial regulators of muscle function. Our study quantified differential dantrolene susceptibility, revealing significantly higher AE risks in MH versus non-MH patients: muscular weakness (ROR: 19.00), respiratory failure (ROR: 5.48), and pulmonary edema (ROR: 22.18). Molecular analysis demonstrated that mutant ryanodine receptor 1 channels amplify IL6\/ALB-mediated respiratory effects and disrupt Adgrl1\/2-regulated muscle function, establishing the mechanistic basis for MH patient vulnerability and supporting MH-specific dosing strategies.<\/jats:p>","DOI":"10.1097\/md.0000000000046304","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T22:00:56Z","timestamp":1764972056000},"page":"e46304","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Systematic analysis of adverse reactions associated with dantrolene treatment: From clinical features to molecular mechanisms"],"prefix":"10.1097","volume":"104","author":[{"given":"Haohui","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, West China Second University Hospital, Sichuan University, Chengdu, People\u2019s Republic of China"},{"name":"Key Laboratory of Birth Deficits and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, People\u2019s Republic of China"},{"name":"West China School of Medicine, Sichuan University, Chengdu, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, West China Second University Hospital, Sichuan University, Chengdu, People\u2019s Republic of China"},{"name":"Key Laboratory of Birth Deficits and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, West China Second University Hospital, Sichuan University, Chengdu, People\u2019s Republic of China"},{"name":"Key Laboratory of Birth Deficits and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, West China Second University Hospital, Sichuan University, Chengdu, People\u2019s Republic of China"},{"name":"Key Laboratory of Birth Deficits and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8855-4701","authenticated-orcid":false,"given":"Chao","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, West China Second University Hospital, Sichuan University, Chengdu, People\u2019s Republic of China"},{"name":"Key Laboratory of Birth Deficits and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260523","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1185\/03007998409109576","article-title":"Long-term treatment with dantrolene sodium of stroke patients with spasticity limiting the return of function.","volume":"9","author":"Ketel","year":"1984","journal-title":"Curr Med Res Opin"},{"key":"R2-20260523","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ageing\/30.1.13","article-title":"Treating depression in old age: the reasons to be positive.","volume":"30","author":"Anderson","year":"2001","journal-title":"Age Ageing"},{"key":"R3-20260523","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/bja\/47.1.62","article-title":"Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.","volume":"47","author":"Harrison","year":"1975","journal-title":"Br J Anaesth"},{"key":"R4-20260523","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/archinte.1989.00390090009002","article-title":"Neuroleptic malignant syndrome. Review of response to therapy.","volume":"149","author":"Rosenberg","year":"1989","journal-title":"Arch Intern Med"},{"key":"R5-20260523","first-page":"45","article-title":"The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature.","volume":"87","author":"Marelli","year":"1996","journal-title":"Minerva Med"},{"key":"R6-20260523","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/jm00317a011","article-title":"1-[(5-arylfurfurylidene)amino]hydantoins. A new class of muscle relaxants.","volume":"10","author":"Snyder","year":"1967","journal-title":"J Med Chem"},{"key":"R7-20260523","first-page":"388","article-title":"Pharmacology of dantrolene sodium in children.","volume":"55","author":"Lietman","year":"1974","journal-title":"Arch Phys Med Rehabil"},{"key":"R8-20260523","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-015-0310-1","article-title":"Malignant hyperthermia: a review.","volume":"10","author":"Rosenberg","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"R9-20260523","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00001665-200309000-00039","article-title":"Malignant hyperthermia.","volume":"14","author":"Halliday","year":"2003","journal-title":"J Craniofac Surg"},{"key":"R10-20260523","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/ALN.0b013e318167aee2","article-title":"Cardiac arrests and deaths associated with malignant hyperthermia in North America from 1987 to 2006: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.","volume":"108","author":"Larach","year":"2008","journal-title":"Anesthesiology"},{"key":"R11-20260523","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/ALN.0000000000002490","article-title":"Succinylcholine use and dantrolene availability for malignant hyperthermia treatment: database analyses and systematic review.","volume":"130","author":"Larach","year":"2019","journal-title":"Anesthesiology"},{"key":"R12-20260523","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/S1481803500012598","article-title":"Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review.","volume":"12","author":"Grunau","year":"2010","journal-title":"CJEM"},{"key":"R13-20260523","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0016-5085(77)80141-8","article-title":"Dantrolene-associated hepatic injury. Incidence and character.","volume":"72","author":"Utili","year":"1977","journal-title":"Gastroenterology"},{"key":"R14-20260523","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1570159X13999150424113345","article-title":"Neuroleptic malignant syndrome: a review from a clinically oriented perspective.","volume":"13","author":"Tse","year":"2015","journal-title":"Curr Neuropharmacol"},{"key":"R15-20260523","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1038\/s41598-022-06611-y","article-title":"Preventive effect of rebamipide on NSAID-induced lower gastrointestinal tract injury using FAERS and JADER.","volume":"12","author":"Imai","year":"2022","journal-title":"Sci Rep"},{"key":"R16-20260523","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2147\/CLEP.S365513","article-title":"A real-world disproportionality analysis of olaparib: data mining of the public version of FDA adverse event reporting system.","volume":"14","author":"Shu","year":"2022","journal-title":"Clin Epidemiol"},{"key":"R17-20260523","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pds.1001","article-title":"The reporting odds ratio and its advantages over the proportional reporting ratio.","volume":"13","author":"Rothman","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R18-20260523","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports.","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R19-20260523","doi-asserted-by":"crossref","first-page":"570","DOI":"10.31083\/ph.2019.9426","article-title":"Signal detection of oral drug-induced dementia in chronic kidney disease patients using association rule mining and Bayesian confidence propagation neural network.","volume":"74","author":"Noguchi","year":"2019","journal-title":"Pharmazie"},{"key":"R20-20260523","doi-asserted-by":"crossref","first-page":"1416985","DOI":"10.3389\/fphar.2024.1416985","article-title":"Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events.","volume":"15","author":"He","year":"2024","journal-title":"Front Pharmacol"},{"key":"R22-20260523","doi-asserted-by":"crossref","first-page":"1112965","DOI":"10.3389\/fcvm.2023.1112965","article-title":"Dantrolene inhibits lysophosphatidylcholine-induced valve interstitial cell calcific nodule formation via blockade of the ryanodine receptor.","volume":"10","author":"Sylvester","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"R23-20260523","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/jps.2600650925","article-title":"Effects of intravenous dantrolene sodium on respiratory and cardiovascular functions.","volume":"65","author":"Ellis","year":"1976","journal-title":"J Pharm Sci"},{"key":"R24-20260523","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1365-2044.2010.06409.x","article-title":"Oral dantrolene and severe respiratory failure in a patient with chronic spinal cord injury.","volume":"65","author":"Javed","year":"2010","journal-title":"Anaesthesia"},{"key":"R25-20260523","doi-asserted-by":"crossref","first-page":"A1199","DOI":"10.1097\/00000542-200209002-01199","article-title":"TNAMH: reassessment of the safety and efficacy of dantrolene: [2002][A-1199].","volume":"96","author":"Brandom","year":"2002","journal-title":"Anesthesiology"},{"key":"R26-20260523","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3389\/fimmu.2017.01644","article-title":"Cytokine-ion channel interactions in pulmonary inflammation.","volume":"8","author":"Hamacher","year":"2017","journal-title":"Front Immunol"},{"key":"R27-20260523","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1007\/s00134-003-2017-3","article-title":"Effect of continuous hemofiltration on hemodynamics, lung inflammation and pulmonary edema in a canine model of acute lung injury.","volume":"29","author":"Su","year":"2003","journal-title":"Intensive Care Med"},{"key":"R28-20260523","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/SHK.0000000000001032","article-title":"Role of receptor for advanced glycation end products in regulating lung fluid balance in lipopolysaccharide-induced acute lung injury and infection-related acute respiratory distress syndrome.","volume":"50","author":"Wang","year":"2018","journal-title":"Shock"},{"key":"R29-20260523","doi-asserted-by":"crossref","first-page":"781874","DOI":"10.3389\/fphys.2021.781874","article-title":"Pulmonary interstitial matrix and lung fluid balance from normal to the acutely injured lung.","volume":"12","author":"Beretta","year":"2021","journal-title":"Front Physiol"},{"key":"R30-20260523","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/jcpt.12161","article-title":"Pharyngeal spasticity due to dantrolene.","volume":"39","author":"Locatelli","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"R31-20260523","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40478-018-0610-5","article-title":"A de novo variant in ADGRL2 suggests a novel mechanism underlying the previously undescribed association of extreme microcephaly with severely reduced sulcation and rhombencephalosynapsis.","volume":"6","author":"Vezain","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"R32-20260523","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-3-319-41523-9_8","article-title":"Adhesion GPCR-related protein networks.","volume":"234","author":"Knapp","year":"2016","journal-title":"Handb Exp Pharmacol"},{"key":"R33-20260523","doi-asserted-by":"crossref","first-page":"138","DOI":"10.30574\/wjbphs.2023.13.1.0021","article-title":"A review on malignant hyperthermia: epidemiology, etiology, risk factors, diagnosis, clinical management and treatment modalities.","volume":"13","author":"Tanwar","year":"2022","journal-title":"World J Biol Pharm Health Sci"},{"key":"R34-20260523","doi-asserted-by":"crossref","first-page":"40210","DOI":"10.1074\/jbc.M106944200","article-title":"RyR3 amplifies RyR1-mediated Ca2+-induced Ca2+ release in neonatal mammalian skeletal muscle.","volume":"276","author":"Yang","year":"2001","journal-title":"J Biol Chem"},{"key":"R35-20260523","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.3390\/ijms24065409","article-title":"Molecular aspects implicated in dantrolene selectivity with respect to ryanodine receptor isoforms.","volume":"24","author":"Gaburjakova","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R36-20260523","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/1566524023362429","article-title":"Malignant hyperthermia: a pharmacogenetic disease of Ca++ regulating proteins.","volume":"2","author":"Nelson","year":"2002","journal-title":"Curr Mol Med"},{"key":"R37-20260523","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.canlet.2021.04.011","article-title":"The TIM3\/Gal9 signaling pathway: an emerging target for cancer immunotherapy.","volume":"510","author":"Kandel","year":"2021","journal-title":"Cancer Lett"},{"key":"R38-20260523","doi-asserted-by":"crossref","first-page":"110031","DOI":"10.1016\/j.celrep.2021.110031","article-title":"Parahippocampal latrophilin-2 (ADGRL2) expression controls topographical presubiculum to entorhinal cortex circuit connectivity.","volume":"37","author":"Donohue","year":"2021","journal-title":"Cell Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:00:26Z","timestamp":1779530426000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":37,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046304","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"2025-08-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}